Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat
Open Access
- 1 November 2004
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 143 (6) , 697-704
Abstract
Calcitonin gene‐related peptide (CGRP) is believed to play a pivotal role in the pathogenesis of migraine via activation of CGRP receptors in the trigeminovascular system. The CGRP receptor antagonist, BIBN4096BS, has proven efficacy in the acute treatment of migraine attacks and represents a new therapeutic principle. We used an improved closed cranial window model to measure changes of the middle meningeal artery (MMA) and cortical pial artery/arteriole diameter (PA) and changes in local cortical cerebral blood flow (LCBFFlux) in anaesthetised artificially ventilated rats. The ability of BIBN4096BS (i.v.) to prevent the vasodilatatory actions of rat‐αCGRP, βCGRP and endogenously released CGRP following transcranial electrical stimulation (TES) was investigated. BIBN4096BS was per se without vasoactive effect on any of the measured variables and significantly inhibited the hypotension induced by both types of CGRP (PαCGRP induced MMA dilatation was reduced from 97.4±14 to 2.1±1.3% (PβCGRP induced dilatation was fully blocked by BIBN4096BS. ID50 was 5.4±1.6 μg kg−1 for αCGRP and 16.3±1.6 μg kg−1 for βCGRP. Transcranial electrical stimulation induced a 119.1±6.9% increase in MMA diameter. BIBN4096BS (333 μg kg−1) attenuated this increase (19.8±2.1%) (PFlux was similar not prevented by the antagonist. We suggest that systemic BIBN4096BS exerts its inhibitory action mainly on large dural blood vessels (MMA). British Journal of Pharmacology (2004) 143, 697–704. doi:10.1038/sj.bjp.0705966Keywords
This publication has 37 references indexed in Scilit:
- Presence and Function of the Calcitonin Gene-Related Peptide Receptor on Rat Pial Arteries Investigated In Vitro and In VivoCephalalgia, 2005
- Effect of Hypotension and Carbon Dioxide Changes in an Improved Genuine Closed Cranial Window Rat ModelCephalalgia, 2005
- Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene‐related peptide induced dilation of dural meningeal vesselsBritish Journal of Pharmacology, 2002
- Immunohistochemical Localization of Calcitonin Receptor–Like Receptor and Receptor Activity–Modifying Proteins in the Human Cerebral VasculatureJournal of Cerebral Blood Flow & Metabolism, 2002
- Origin and co‐localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the ratMicroscopy Research and Technique, 2001
- Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonistBritish Journal of Pharmacology, 2000
- Vasoactive peptide release in the extracerebral circulation of humans during migraine headacheAnnals of Neurology, 1990
- Effects of Neuropeptide Y and Calcitonin Gene-Related Peptide on Local Cerebral Blood Flow in Rat StriatumJournal of Cerebral Blood Flow & Metabolism, 1989
- Neurogenically Mediated Plasma Extravasation in Dura Mater: Effect of Ergot Alkaloids: A Possible Mechanism of Action in Vascular HeadacheCephalalgia, 1988
- Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular systemAnnals of Neurology, 1988